British Patient Capital

British Patient Capital

Overview

British Patient Capital is the UK's largest domestic investor in venture and venture growth opportunities . With more than £3bn of assets under management, its mission is to enable long-term investment in innovative UK companies led by ambitious entrepreneurs who want to build successful, world-class businesses . By focusing on the late-stage funding gap, it helps ensure high-growth UK companies have access to the right type of funding at the right time in their life-cycle, supporting them as they expand, create jobs, develop products and enter new markets .

Year Founded

2018

Portfolio Companies

34

Investments

CompanyDateStageLead
Nuclera NucleicsJan 2026Series CCo-investor
ParagrafAug 2025Series CCo-investor
Maxion TherapeuticsMar 2025Series ACo-investor
QuantexaMar 2025Series F-
Cambridge GaN DevicesFeb 2025Series CCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersUnited Kingdom
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.